Pub. Date : 2017 Mar 9
PMID : 28276433
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | However, over the past decade, marked advances in the treatment of metastatic RCC have been made, with targeted agents including sorafenib, sunitinib, bevacizumab, pazopanib and axitinib, which inhibit vascular endothelial growth factor (VEGF) and its receptor (VEGFR), and everolimus and temsirolimus, which inhibit mechanistic target of rapamycin complex 1 (mTORC1), being approved. | Sorafenib | CREB regulated transcription coactivator 1 | Mus musculus |